Clinicopathological and Prognostic Significance of NCALD Protein Expression in Lung Adenocarcinoma

Overview

Journal Transl Cancer Res

Specialty Oncology

Date 2022 Feb 4

PMID 35116813

Authors

Yi Chen

Xueren Feng

Hui Shen

Lijuan Zhang

Xiaoyong Li

Liliang Gao

Xiaohuo Zhang

Bin Wang

Affiliations

Soon will be listed here.

Abstract

Background: Although there are great improvements in diagnostics and treatment of non-small cell lung cancer (NSCLC), it remains the leading cause of cancer-related death globally. NSCLC can be further categorized into two common subtypes, lung squamous cell carcinoma (LUSC) and lung adenocarcinoma (LUAD). The aims of this study were to evaluate the expression of neurocalcin delta (NCALD) in LUAD patients and to evaluate the relationship between NCALD expression and clinicopathological feature as well as overall survival (OS).

Methods: The expression level of NCALD protein was assessed by immunohistochemical analysis of tissue microarrays (TMAs) which contained 90 LUAD tissues and paired adjacent normal tissues. The relationship between NCALD expression level and clinicopathological characteristics as well as OS were investigated.

Results: The results showed that the expression level of NCALD protein in LUAD tissues was significantly down-regulated (P<0.01) and that the NCALD level was correlated with the tumor size (P<0.001), lymph node metastasis (P=0.03) and TNM stage (P=0.015). Both Kaplan-Meier survival analysis and Cox regression univariate analysis identified that NCALD expression level, lymph node metastasis, and clinical TNM stages were prognostic factors for patients' survival (P<0.05).

Conclusions: Overexpression of NCALD is a significant marker for a good prognosis in patients with LUAD.

Citing Articles

Prognostic significance of AP-2α/γ targets as cancer therapeutics.

Kolat D, Kaluzinska Z, Bednarek A, Pluciennik E Sci Rep. 2022; 12(1):5497.

PMID: 35361846 PMC: 8971500. DOI: 10.1038/s41598-022-09494-1.

References

Burgoyne R, Weiss J . The neuronal calcium sensor family of Ca2+-binding proteins. Biochem J. 2000; 353(Pt 1):1-12. PMC: 1221537. View

Mahloogi H, Gonzalez-Guerrico A, De Cicco R, Bassi D, Goodrow T, Braunewell K . Overexpression of the calcium sensor visinin-like protein-1 leads to a cAMP-mediated decrease of in vivo and in vitro growth and invasiveness of squamous cell carcinoma cells. Cancer Res. 2003; 63(16):4997-5004. View

Isaksson H, Sorbe B, Nilsson T . Whole genome expression profiling of blood cells in ovarian cancer patients -prognostic impact of the CYP1B1, MTSS1, NCALD, and NOP14. Oncotarget. 2014; 5(12):4040-9. PMC: 4147304. DOI: 10.18632/oncotarget.1938. View

Wickborn C, Klein-Szanto A, Schlag P, Braunewell K . Correlation of visinin-like-protein-1 expression with clinicopathological features in squamous cell carcinoma of the esophagus. Mol Carcinog. 2006; 45(8):572-81. DOI: 10.1002/mc.20201. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2015. CA Cancer J Clin. 2015; 65(1):5-29. DOI: 10.3322/caac.21254. View

Fu J, Fong K, Bellacosa A, Ross E, Apostolou S, Bassi D . VILIP-1 downregulation in non-small cell lung carcinomas: mechanisms and prediction of survival. PLoS One. 2008; 3(2):e1698. PMC: 2246032. DOI: 10.1371/journal.pone.0001698. View

Ettinger D, Akerley W, Bepler G, Blum M, Chang A, Cheney R . Non-small cell lung cancer. J Natl Compr Canc Netw. 2010; 8(7):740-801. DOI: 10.6004/jnccn.2010.0056. View

Jheng F, Wang L, Lee L, Chang L . Functional contribution of Ca2+ and Mg2+ to the intermolecular interaction of visinin-like proteins. Protein J. 2006; 25(4):250-6. DOI: 10.1007/s10930-006-9008-5. View

Shi X, Ma C, Zhu Q, Yuan D, Sun M, Gu X . Upregulation of long intergenic noncoding RNA 00673 promotes tumor proliferation via LSD1 interaction and repression of NCALD in non-small-cell lung cancer. Oncotarget. 2016; 7(18):25558-75. PMC: 5041926. DOI: 10.18632/oncotarget.8338. View

10.

Couvelard A, Hu J, Steers G, OToole D, Sauvanet A, Belghiti J . Identification of potential therapeutic targets by gene-expression profiling in pancreatic endocrine tumors. Gastroenterology. 2006; 131(5):1597-610. DOI: 10.1053/j.gastro.2006.09.007. View

11.

Wang W, Zhou Z, Zhao W, Huang Y, Tang R, Ying K . Molecular cloning, mapping and characterization of the human neurocalcin delta gene (NCALD). Biochim Biophys Acta. 2001; 1518(1-2):162-7. DOI: 10.1016/s0167-4781(00)00290-6. View

12.

Iino S, Kobayashi S, Hidaka H . Neurocalcin-immunopositive nerve terminals in the muscle spindle, Golgi tendon organ and motor endplate. Brain Res. 1998; 808(2):294-9. DOI: 10.1016/s0006-8993(98)00750-1. View

13.

Zhang Y, Liu Y, Duan J, Yan H, Zhang J, Zhang H . Hippocalcin-like 1 suppresses hepatocellular carcinoma progression by promoting p21(Waf/Cip1) stabilization by activating the ERK1/2-MAPK pathway. Hepatology. 2015; 63(3):880-97. DOI: 10.1002/hep.28395. View

14.

Cooper W, Lam D, OToole S, Minna J . Molecular biology of lung cancer. J Thorac Dis. 2013; 5 Suppl 5:S479-90. PMC: 3804875. DOI: 10.3978/j.issn.2072-1439.2013.08.03. View

15.

Gonzalez Guerrico A, Jaffer Z, Page R, Braunewell K, Chernoff J, Klein-Szanto A . Visinin-like protein-1 is a potent inhibitor of cell adhesion and migration in squamous carcinoma cells. Oncogene. 2005; 24(14):2307-16. DOI: 10.1038/sj.onc.1208476. View

16.

Riessland M, Kaczmarek A, Schneider S, Swoboda K, Lohr H, Bradler C . Neurocalcin Delta Suppression Protects against Spinal Muscular Atrophy in Humans and across Species by Restoring Impaired Endocytosis. Am J Hum Genet. 2017; 100(2):297-315. PMC: 5294679. DOI: 10.1016/j.ajhg.2017.01.005. View

17.

Osada H, Takahashi T . Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. Oncogene. 2002; 21(48):7421-34. DOI: 10.1038/sj.onc.1205802. View

18.

OCallaghan D, Ivings L, Weiss J, Ashby M, Tepikin A, Burgoyne R . Differential use of myristoyl groups on neuronal calcium sensor proteins as a determinant of spatio-temporal aspects of Ca2+ signal transduction. J Biol Chem. 2002; 277(16):14227-37. DOI: 10.1074/jbc.M111750200. View

19.

Belinsky S . Silencing of genes by promoter hypermethylation: key event in rodent and human lung cancer. Carcinogenesis. 2005; 26(9):1481-7. DOI: 10.1093/carcin/bgi020. View

20.

Minna J, Roth J, Gazdar A . Focus on lung cancer. Cancer Cell. 2002; 1(1):49-52. DOI: 10.1016/s1535-6108(02)00027-2. View